Univariate analysis
|
Multivariate analysis
|
---|
Characteristics
|
n
|
Prevalence of anaemia n (%)
|
P-value
|
AOR
|
95% CI
|
P-value
|
---|
Malaria infection
| | | | | | |
Yes
|
19
|
18 (94.7)
| |
10.363
|
1.329-80.798
|
0.026
|
No (reference)
|
401
|
209 (52.1)
|
0.0001a
|
1
| | |
History of malaria illness
| | | | | | |
Yes
|
107
|
76 (71)
| |
1.746
|
1.005-3.033
|
0.048
|
No (reference)
|
313
|
151 (48.2)
|
0.0001a
|
1
| | |
WHO clinical stage
| | | | | | |
Stage I (reference)
|
338
|
165 (48.8)
| |
1
| | |
Stage II
|
43
|
32 (74.4)
| |
3.076
|
1.458-6.491
|
0.003
|
Stage III-IV
|
37
|
30 (76.9)
|
0.0001a
|
2.653
|
1.184-5.945
|
0.018
|
CD4 count (cells/μL)*
| | | | | | |
≥500
|
104
|
48 (46.2)
| |
-
| | |
350-499
|
85
|
45 (52.9)
| |
-
| | |
200-349
|
96
|
62 (64.6)
| |
−
| | |
<200
|
59
|
42 (71.2)
|
0.005a
|
-
| | |
Pregnancy trimester
| | | | | | |
1st trimester
|
20
|
9 (45)
| |
-
| | |
2nd trimester
|
206
|
107 (51.9)
| |
-
| | |
3rd trimester
|
194
|
111 (57.2)
|
0.404a
|
-
| | |
Gravidity
| | | | | | |
Primigravidae
|
139
|
72 (51.8)
| |
-
| | |
Secundigravidae
|
148
|
83 (56.1)
| |
-
| | |
Multigravidae
|
133
|
72 (54.1)
|
0.767a
|
-
| | |
ITN use
| | | | | | |
Yes
|
380
|
201 (52.9)
| |
-
| | |
No
|
40
|
26 (65)
|
0.144a
|
-
| | |
ART category
| | | | | | |
ARV Prophylaxis
|
288
|
146 (50.7)
| |
-
| | |
Life-long ART
|
132
|
81 (61.4)
|
0.142a
|
-
| | |
Duration of AZT use (months)
| | | | | | |
<3
|
162
|
93 (57.4)
| |
-
| | |
3-5.9
|
168
|
92 (54.8)
| |
−
| | |
≥6
|
90
|
42 (46.7)
|
0.253a
|
-
| | |
Iron supplements
| | | | | | |
Yes
|
338
|
185 (54.7)
| |
-
| | |
No
|
82
|
42 (51.2)
|
0.567a
|
-
| | |
Use of de-worming drug
| | | | | | |
Yes
|
327
|
171 (52.3)
| |
-
| | |
No
|
93
|
56 (60.2)
|
0.176a
|
-
| | |
Adherence to co-trimoxazole
| | | | | | |
Good (reference)
|
208
|
92 (44.2)
| |
1
| | |
Average
|
80
|
47 (58.8)
| |
1.478
|
0.848-2.578
|
0.168
|
Poor
|
132
|
88(66.7)
|
0.0001a
|
1.752
|
1.03-2.979
|
0.039
|
-
aCalculated by Pearson Chi Square, *Results of CD4 Count were available for only 344 subjects out of 420 (81.9%).